Federica Fascì-Spurio
Federica Fascì-Spurio has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Claudia Reytor-González
Center for Evidence Ecosystems, Implementation Science, and Decision-Making (CIDES), Facultad de Ciencias de la Salud y Bienestar Humano, Universidad Tecnológica Indoamérica, Ambato 180150, Ecuador
2 shared publications - Daniel Simancas-Racines
Center for Evidence Ecosystems, Implementation Science, and Decision-Making (CIDES), Facultad de Ciencias de la Salud y Bienestar Humano, Universidad Tecnológica Indoamérica, Ambato 180150, Ecuador
2 shared publications - Evelyn Frias-Toral
School of Medicine, Universidad Católica de Santiago de Guayaquil, Av. Pdte. Carlos Julio Arosemena Tola, Guayaquil 090615, Ecuador
2 shared publications - Andri Matos
School of Allied Health, Eastwick College, Ramsey, NJ 07446, USA
1 shared publication - Carlos Soria
Hospital de Lima Este Vitarte, Ctra. Central KM 7.5, Ate 15491, Peru
1 shared publication - Dolores Jima Gavilanes
Escuela de Medicina, Universidad Espíritu Santo, Samborondón 0901952, Ecuador
1 shared publication
Latest Publications
- Open Access
- 19 June 2026
- Published by Elsevier in Obesity Pillars
- Vol. 19
Micronutrient risk with GLP-1 receptor and dual incretin agonists in obesity: Mechanistic pathways, clinical signals, and a monitoring framework
- 19 June 2026
- Published by Elsevier in Obesity Pillars
- Vol. 19
Open AccessMicronutrient risk with GLP-1 receptor and dual incretin agonists in obesity: Mechanistic pathways, clinical signals, and a monitoring framework
- Open Access
- 20 April 2025
- Published by Taylor & Francis in Food and Agricultural Immunology
- Vol. 36 (1)
Obesity and nutritional strategies: advancing prevention and management through evidence-based approaches
- 20 April 2025
- Published by Taylor & Francis in Food and Agricultural Immunology
- Vol. 36 (1)
Open AccessObesity and nutritional strategies: advancing prevention and management through evidence-based approaches
- Top Cited PapersOpen Access
- 11 January 2025
- Published by Springer Nature in Current Obesity Reports
- Vol. 14 (1) , 1-16
Nutritional Strategies for Battling Obesity-Linked Liver Disease: the Role of Medical Nutritional Therapy in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management
Purpose of Review This narrative review explores the role of Medical Nutritional Therapy (MNT) in managing Metabolic-Associated Steatotic Liver Disease (MASLD), previously known as nonalcoholic fatty liver disease. It aims to examine the effectiveness of specific nutritional strategies in preventing and treating this obesity-linked liver disease. Recent Findings Emerging evidence underscores the benefits of the Mediterranean diet, low-carbohydrate diets, and intermittent fasting in reducing liver fat, improving insulin sensitivity, and mitigating inflammation. Supplementing with vitamin E, omega-3 fatty acids, and silymarin can potentially reduce liver fibrosis and promote liver health. Summary MNT is a key intervention for MASLD management, emphasizing dietary patterns, caloric restriction, and nutraceutical supplementation. Integrating these strategies with lifestyle modifications, including regular physical activity, offers a comprehensive approach to improving metabolic and liver outcomes in patients with MASLD. Further research is needed to refine and personalize these therapeutic interventions.
- 11 January 2025
- Published by Springer Nature in Current Obesity Reports
- Vol. 14 (1) , 1-16
Top Cited PapersOpen AccessNutritional Strategies for Battling Obesity-Linked Liver Disease: the Role of Medical Nutritional Therapy in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management
Purpose of Review This narrative review explores the role of Medical Nutritional Therapy (MNT) in managing Metabolic-Associated Steatotic Liver Disease (MASLD), previously known as nonalcoholic fatty liver disease. It aims to examine the effectiveness of specific nutritional strategies in preventing and treating this obesity-linked liver disease. Recent Findings Emerging evidence underscores the benefits of the Mediterranean diet, low-carbohydrate diets, and intermittent fasting in reducing liver fat, improving insulin sensitivity, and mitigating inflammation. Supplementing with vitamin E, omega-3 fatty acids, and silymarin can potentially reduce liver fibrosis and promote liver health. Summary MNT is a key intervention for MASLD management, emphasizing dietary patterns, caloric restriction, and nutraceutical supplementation. Integrating these strategies with lifestyle modifications, including regular physical activity, offers a comprehensive approach to improving metabolic and liver outcomes in patients with MASLD. Further research is needed to refine and personalize these therapeutic interventions.